Exogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancer

BACKGROUND: Insulin-like growth factors (IGF-I and IGF-II) signal via the type 1 IGF receptor (IGF-1R) and IGF-II also activates the insulin receptor isoform A (IR-A). Signalling via both receptors promotes tumour growth, survival and metastasis. In some instances IGF-II action via the IR-A also pro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Soh, C-L, McNeil, K, Owczarek, C M, Hardy, M P, Fabri, L J, Pearse, M, Delaine, C A, Forbes, B E
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2014
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4056053/
https://ncbi.nlm.nih.gov/pubmed/24853186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.232
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados